Autologous hematopoietic stem cell transplantation for autoimmune diseases

Acta Haematologica

Volumn 114, Issue 4, 2005, Pages 239-247

  Tyndall, Alan ^a,b   Daikeler, Thomas ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Felix Platter Spital ^*  (Switzerland)

Author keywords

Autoimmune disease; Bone marrow; Stem cell; Transplant

Indexed keywords

ANTIRHEUMATIC AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE; MITOXANTRONE; THYMOCYTE ANTIBODY;

AORTA ARCH SYNDROME; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BEHCET DISEASE; CD34 SELECTION; CELLULAR IMMUNITY; CHURG STRAUSS SYNDROME; CLINICAL TRIAL; DRUG FATALITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MORTALITY; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; POLYARTERITIS NODOSA; POLYCHONDRITIS; PRIORITY JOURNAL; RANDOMIZATION; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; TREATMENT OUTCOME; VASCULITIS; WEGENER GRANULOMATOSIS;

AUTOIMMUNE DISEASES; BIOMEDICAL RESEARCH; CLINICAL TRIALS, PHASE III; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 27644587538     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088415     Document Type: Article

References (71)

1. Marmont AM, Gratwohl A, Vischer T: Haemopoietic precursor-cell transplants for autoimmune diseases. Lancet 1995;345:978.
2. Tyndall A, Gratwohl A: Blood and marrow stem cell transplants in auto-immune disease: A consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997;19:643-645.
3. Sullivan KM, Furst DE: The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. J Rheumatol Suppl 1997;48:1-4.
4. Hinterberger W, Hinterberger-Fischer M, Marmont A: Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002;30:753-759.
5. Slavin S, Nagler A, Varadi G, Or R: Graft vs. autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000;28:853-857.
6. Davidson A, Diamond B: Autoimmune diseases. N Engl J Med 2001;345:340-350.
7. Medzhitov R, Janeway CA Jr: Decoding the patterns of self and nonself by the innate immune system. Science 2002;296:298-300.
8. van Bekkum DW: Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract Res Clin Haematol 2004;17:201-222.
9. Roep BO, Atkinson M: Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal. Diabetologia 2004;47:1650-1656.
10. Ikehara S: Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp Hematol 2001;29:661-669.
11. Knaan-Shanzer S, Houben P, Kinwel-Bohre EP, van Bekkum DW: Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991;8:333-338.
12. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, et al: Twin concordance rates for rheumatoid arthritis: Results from a nationwide study. Br J Rheumatol 1993;32:903-907.
13. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 1996;85:291-297.
14. Marmont AM: Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol 2004;17:223-232.
15. Sturfelt G, Lenhoff S, Sallerfors B, Nived O, Truedsson L, Sjoholm AG: Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): Successful outcome in the recipient and induction of an SLE flare in the donor. Ann Rheum Dis 1996;55:638-641.
16. Openshaw H, Lund BT, Kashyap A, Atkinson R, Sniecinski I, Weiner LP, et al: Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring. Biol Blood Marrow Transplant 2000;6(5A):563-575.
17. McKendry RJ, Huebsch L, Leclair B: Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year follow-up. Arthritis Rheum 1996;39: 1246-1253.
18. Durez P, Toungouz M, Schandene L, Lambermont M, Goldman M: Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis. Lancet 1998;352:881.
19. McColl G, Kohsaka H, Szer J, Wicks I: High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 1999;131:507-509.
20. Pavletic SZ, Odell JR, Pirruccello SJ, Ursick MM, Haire CE, Sharp JG, et al: Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience. J Rheumatol Suppl 2001;64:13-20.
21. Bingham SJ, Snowden J, McGonagle D, Richards S, Isaacs J, Morgan G, et al: Autologous stem cell transplantation for rheumatoid arthritis - interim report of 6 patients. J Rheumatol Suppl 2001;64:21-24.
22. Verburg RJ, Kruize AA, van den Hoogen FH, Fibbe WE, Petersen EJ, Preijers F, et al: High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 2001;44:754-760.
23. Kim KC, Lee IH, Choi JH, Oh MR, Ahn MJ, Kim SY: Autologous stem cell transplantation in the treatment of refractory rheumatoid arthritis. J Korean Med Sci 2002;17:129-132.
24. Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M, et al: A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002;46:2301-2309.
25. Lanza F, Dominici M, Govoni M, Moretti S, Campioni D, Corte RL, et al: Prolonged remission state of refractory adult onset Still's disease following CD34-selected autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2000;25:1307-1310.
26. Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W: Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999;353:550-553.
27. Quartier P, Prieur AM, Fischer A: Haemopoietic stem-cell transplantation for juvenile chronic arthritis. Lancet 1999;353:1885-1886.
28. Nakagawa R, Kawano Y, Yoshimura E, Suzuya H, Watanabe T, Kanamaru S, et al: Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis. Bone Marrow Transplant 2001;27:333-336.
29. Tyndall A, Black C, Finke J, Winkler J, Mertlesmann R, Peter HH, et al: Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 1997;349:254.
30. Martini A, Maccario R, Ravelli A, Montagna D, De Benedetti F, Bonetti F, et al: Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis. Rheumatology (Oxford) 1999;38:773.
31. McSweeney PA, Nash RA, Sullivan KM, Storek J, Crofford LJ, Dansey R, et al: High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 2002;100:1602-1610.
32. Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N, et al: Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study. Br J Haematol 2002;119:726-739.
33. Marmont AM, van Lint MT, Gualandi F, Bacigalupo A: Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997;6:545-548.
34. Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R et al: Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 1998;7:492-494.
35. Fouillard L, Gorin NC, Laporte JP, Leon A, Brantus JF, Miossec P: Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+-purified autologous stem cells from peripheral blood. Lupus 1999;8:320-323.
36. Trysberg E, Lindgren I, Tarkowski A: Autologous stem cell transplantation in a case of treatment resistant central nervous systemic lupus. Ann Rheum Dis 2000;59:236-238.
37. Shaughnessy PJ, Ririe DW, Ornstein DL, Kissack B, Bickford DJ, Molina R, et al: Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue. Bone Marrow Transplant 2001;27:221-224.
38. Rosen O, Hiepe F, Massenkeil G, Thiel A, Arnold R: Relapse of systemic lupus erythematosus. Lancet 2001;357:807-808.
39. Wulffraat NM, Sanders EA, Kamphuis SS, Rijkers GT, Kuis W, Lilien M, et al: Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum 2001;44:728-731.
40. Brunner M, Greinix HT, Redlich K, Knobl P, Smolen J, Leitner G, et al: Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: A case report. Arthritis Rheum 2002;46:1580-1584.
41. Traynor AE, Barr WG, Rosa RM, Rodriguez J, Oyama Y, Baker S, et al: Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum 2002;46:2917-2923.
42. Myllykangas-Luosujarvi R, Jantunen E, Kaipiainen-Seppanen O, Mahlamaki E, Nousiainen T: Autologous peripheral blood stem cell transplantation in a patient with severe mixed connective tissue disease. Scand J Rheumatol 2000;29:326-327.
43. Baron F, Ribbens C, Kaye O, Fillet G, Malaise M, Beguin Y: Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. Br J Haematol 2000;110:339-342.
44. Bingham S, Griffiths B, McGonagle D, Snowden JA, Morgan G, Emery P: Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up. Br J Haematol 2001;113:840-841.
45. Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D, et al: T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: Report on the first three patients. Bone Marrow Transplant 1998;21:537-541.
46. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, et al: Autologous stem cell transplantation in progressive multiple sclerosis - an interim analysis of efficacy. J Clin Immunol 2000;20:24-30.
47. Kozak T, Havrdova E, Pit'ha J, Gregora E, Pytlik R, Maaloufova J, et al: High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 2000;25:525-531.
48. Burt RK, Traynor A, Oyama Y, Craig R: High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood 2003;101:2064-2066.
49. Rosen O, Thiel A, Massenkeil G, Hiepe F, Haupl T, Radtke H, et al: Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2000;2:327-336.
50. Rabusin M, Andolina M, Maximova N, Lepore L, Parco S, Tuveri G, et al: Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease. Haematologica 2000;85 (suppl):81-85.
51. Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R: Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease. Am J Hematol 2001;66:75-79.
52. Gratwohl A, Passweg J, Gerber I, Tyndall A: Stem cell transplantation for autoimmune diseases. Best Pract Res Clin Haematol 2001;14:755-776.
53. Saccardi R, Tyndall A, Coghlan G, Denton C, Edan G, Emdin M, et al: Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant 2004;34:877-881.
54. Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, et al: Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 2001;60:577-584.
55. Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, et al: Autologous stem cell transplantation in the treatment of systemic sclerosis: Report from the EBMT/EULAR Registry. Ann Rheum Dis 2004;63:974-981.
56. Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Laar J, et al: Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J Rheumatol 2004;31:482-488.
57. Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, et al: Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 2002;249:1088-1097.
58. Wulffraat NM, de Kleer IM, Prakken BJ, Kuis W: Stem cell transplantation for autoimmune disorders. Refractory juvenile idiopathic arthritis. Best Pract Res Clin Haematol 2004;17:277-289.
59. Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R, et al: Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004;13:168-176.
60. Jayne D, Tyndall A: Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004;13:359-365.
61. Hensel M, Breitbart A, Ho AD: Autologous hematopoietic stem-cell transplantation for Behçet's disease with pulmonary involvement. N Engl J Med 2001;344:69.
62. Rossi G, Moretta A, Locatelli F: Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behçet disease. Blood 2004;103:748-750.
63. Voltarelli JC, Oliveira MC, Stracieri AB, Godoi DF, Moraes DA, Coutinho MA, et al: Haematopoietic stem cell transplantation for refractory Takayasu's arteritis. Rheumatology (Oxford) 2004;43:1308-1309.
64. Kalwak K, Gorczynska E, Toporski J, Turkiewicz D, Slociak M, Ussowicz M, et al: Immune reconstitution after haematopoietic cell transplantation in children: Immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 2002;118:74-89.
65. Peggs KS, Verfuerth S, Pizzey A, Khan N, Moss P, Goldstone AH, et al: Reconstitution of T-cell repertoire after autologous stem cell transplantation: Influence of CD34 selection and cytomegalovirus infection. Biol Blood Marrow Transplant 2003;9:198-205.
66. Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, et al: Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000;355:1875-1881.
67. Crippa F, Holmberg L, Carter RA, Hooper H, Marr KA, Bensinger W, et al: Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2002;8:281-289.
68. Aubert G, Hassan-Walker AF, Madrigal JA, Emery VC, Morte C, Grace S, et al: Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis 2001;184:955-963.
69. Einsele H, Bertz H, Beyer J, Kiehl MG, Runde V, Kolb HJ, et al: Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82(suppl 2):S175-S185.
70. Petri M, Jones RJ, Brodsky RA: High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum 2003;48:166-173.
71. Wedderburn LR, Jeffery R, White H, Patel A, Varsani H, Linch D, Murray K, Woo P: Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO(+) to RA(+) phenotype. Rheumatology 2001;40:1299-1307.